Ghrelin induces proliferation in human aortic endothelial cells via ERK1/2 and PI3K/Akt activation

Peptides

Volumn 29, Issue 11, 2008, Pages 2046-2051

  Rossi, Fabio ^a   Castelli, Antonella ^a   Bianco, Maria J ^a   Bertone, Cora ^a   Brama, Marina ^a   Santiemma, Vittorio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aorta; Endothelial cell; Ghrelin; Proliferation

Indexed keywords

GHRELIN; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B;

AORTA; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENINE; ANDROSTADIENES; AORTA; CARBAZOLES; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FLAVONOIDS; GHRELIN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-AKT; PYRROLES;

ANIMALIA;

EID: 54049141243     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.07.002     Document Type: Article

References (34)

1. Baiguera S., Conconi M.T., Guidolin D., Mazzocchi G., Malendowicz L.K., Parnigotto P.P., et al. Ghrelin inhibits in vitro angiogenic activity of rat brain microvascular endothelial cells. Int J Mol Med 4 (2004) 849-854
2. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/Akt. J Cell Biol 159 (2002) 1029-1037
3. Bodart V., Bouchard J.F., McNicoll N., Escher E., Carriere P., Ghigo E., et al. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart. Circ Res 85 (1999) 796-808
4. Camiña J.P., Lodeiro M., Ischenko O., Martini A.C., and Casanueva F.F. Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: role of G-proteins and beta-arrestins. J Cell Physiol 213 (2007) 187-200
5. Cao J.M., Ong H., and Chen C. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol Metab 17 (2006) 13-18
6. Casanueva F.F., and Diéguez C. Ghrelin: the link connecting growth with metabolism and energy homeostasis. Rev Endocr Metabol Disord 3 (2002) 325-338
7. Cassoni P., Papotti M., Ghe C., Catapano F., Sapino A., Graziani A., et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 86 (2001) 1738-1745
8. Chung H., Seo S., Moon M., and Park S. Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3{beta} and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J Endocrinol Jun 9 (2008) [Epub ahead of print]
9. Conconi M.T., Nico B., Guidolin D., Baiguera S., Spinazzi R., Rebuffat P., et al. Ghrelin inhibits FGF-2 mediated angiogenesis in vitro and in vivo. Peptides 25 (2004) 2179-2185
10. Duxbury M.S., Waseem T., Ito H., Robinson M.K., Zinner M.J., Ashley S.W., et al. Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem Biophys Res Commun 309 (2003) 464-468
11. Enomoto M., Nagaya N., Uematsu M., Okumura H., Nakagawa E., Ono F., et al. Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin Sci 105 (2003) 431-435
12. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87 (2002) 2988
13. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., et al. Van der Ploeg LH, Howard AD. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 48 (1997) 23-29
14. Iglesias M.J., Pineiro R., Blanco M., Gallego R., Dieguez C., Gualillo O., et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 62 (2004) 481-488
15. Jeffery P.L., Herington A.C., and Chopin L.K. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol 172 (2002) R7-R11
16. Katugampola S.D., Pallikaros Z., and Davenport A.P. [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with atherosclerosis. Br J Pharmacol 134 (2001) 143-149
17. Kleinz M.J., Maguire J.J., Skepper J.N., and Davenport A.P. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res 69 (2006) 227-235
18. Kojima M., and Kangawa K. Drug insight: the functions of ghrelin and its potential as a multitherapeutic hormone. Nat Clin Pract Endocrinol Metab 2 (2006) 80-88
19. Korbonits M. Ghrelin-a hormone with multiple functions. Front Neuroendocrinol 25 (2004) 27-68
20. Lia A., Cheng G., Zhu G.H., and Tarnawski A.S. Ghrelin stimulates angiogenesis in human microvascular endothelial cells: implications beyond GH release. Biochem Biophys Res Commun 9 (2007) 238-243
21. McLaughlin T., Abbasi F., Lamendola C., Frayo R.S., and Cummings D.E. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 89 (2004) 1630-1635
22. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280 (2001) R1483-R1487
23. Papazisis K.T., Geromichalos G.D., Dimitriadis K.A., and Kortsaris A.H. Optimization of the sulforhodamine B colorimetric assay. J Immunol Methods 208 Oct 27 (2) (1997) 151-158
24. Poykko S.M., Kellokoski E., Horkko S., Kauma H., Kesaniemi Y.A., and Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52 (2003) 2546-2553
25. Rossi F., Bertone C., Petricca S., and Santiemma V. Ghrelin inhibits angiotensin II-induced migration of human aortic endothelial cells. Atherosclerosis 192 (2006) 291-297
26. Rossi F, Castelli A, Bianco MJ, Bertone C, Brama M, Santiemma V. Ghrelin inhibits contraction and proliferation of human aortic smooth muscle cells by cAMP/PKA pathway activation, doi:10.1016/j.atherosclerosis.2008.06.015.
27. Saxena M., Williams S., Taskén K., and Mustelin T. Crosstalk between cAMPdependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat Cell Biol 1 (1999) 305-311
28. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87 (2002) 240-244
29. Smith R.G. Development of growth hormone secretagogues. Endocr Rev 26 (2005) 346-360
30. Stork P.J.S., and Schmitt J.M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12 (2002) 258-266
31. Tolle V., Bassant M.H., Zizzari P., Poindessous-Jazat F., Tomasetto C., Epelbaum J., et al. Ultradian rhythmicity of Ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 143 (2002) 1353-1361
32. Vossler M.R., Yao H., York R.D., Pan M.G., Rim C.S., and Stork P.J. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89 (1997) 73-82
33. Wojnowski L., Zimmer A.M., Beck T.W., Hahn H., Bernal R., Rapp U.R., et al. Endothelial apoptosis in Braf-deficient mice. Nat Genet 16 (1997) 293-297
34. Young S.W., Dickens M., and Tavaré J.M. Differentiation of PC12 cells in response to a cAMP analogue is accompanied by sustained activation of mitogenactivated protein kinase. Comparison with the effects of insulin, growth factors and phorbol esters. FEBS Lett 338 (1994) 212-221